{
  "page_number": 50,
  "text": " \n \n45 \n \n• \nPresence of 2 or more of the following symptoms - Pelvic pain, Pyrexia i.e. oral temperature \n38.5°C or higher on any occasion, Abnormal vaginal discharge, e.g. presence of pus or \ndischarge with a foul odour, Delay in the rate of reduction of the size of the uterus (<2cm/day \nduring the first 8 days) indicate puerperal sepsis.  \n• \nIt is important to consider and cover C. sordelli and C. perfringens in emergency sepsis cases \n \n6.9 Urethral discharge syndrome  \nRefer to: National Technical Guidelines on Sexually Transmitted Infections and Reproductive Tract \nInfections (2024). Pg 34-38. National AIDS Control Organization, Ministry of Health and Family Welfare, \nGovernment of India.2024.6  \nFor common etiological agents of urethral discharge syndrome, see Annexure B.6.9 \n \n6.10 Chorio-amnionitis \nType of Infection \nFirst Line (with Dosage and \nDuration) \nAlternative (with \ndosage and Duration) \nComments \nChorio-amnionitis \nAmpicillin 2g IV q6h  \n+ \nGentamicin 5 mg/kg daily \nOD IV \n+ \nMetronidazole 500mg IV q8 \nh \nOr \nAmoxicillin-clavulanic acid \n1.2g q8h for 7-10 days \nClindamycin 600 IV q8h \n+  \nGentamicin 5 mg/kg \ndaily IV for 7-10 days \n \n \nChorio-amnionitis \n(Sepsis)  \nInj Piperacillin-tazobactam \n4.5g IV q6h for 7-14 days \nImipenem 500mg IV \nq6h / Meropenem 1-2g \nIV q8h \n+/- \nAmikacin 15 mg/kg IV \nOD  \nfor 7-10 days \nIf the patient is in \nseptic shock, consider \nadding Vancomycin or \nTeicoplanin to cover \nMRSA. \nFor common etiological agents of Chorioamnionitis, see Annexure B.6.10 \nReferences: \n1. Guidelines for the management of symptomatic sexually transmitted infections. Geneva: \nWorld Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. Available from: \nhttps://iris.who.int/bitstream/handle/10665/342523/9789240024168-eng.pdf?sequence=1 \n2. STI Guidelines \n2021, CDC, MMWR \nRecomm \nRep \n2021;70(4). \nAvailable \nfrom: \nhttps://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf \n \n6 https://naco.gov.in/sites/default/files/National%20Technical%20Guidelines%20on%20STI%20and%20RTI_Final.pdf \n \n",
  "tables": [
    {
      "headers": [
        "Type of Infection First Line (with Dosage and Alternatvie (with Comments\nDuration) dosage and Duration)",
        "Col1",
        "Col2",
        "Col3"
      ],
      "rows": [
        [
          "Chorio-amnionitsi",
          "Ampicillin 2g IV q6h\n+\nGentamicin 5 mg/kg daily\nOD IV\n+\nMetronidazole 500mg IV q8\nh\nOr\nAmoxicillin-clavulanic acid\n1.2g q8h for 7-10 days",
          "Clindamycin 600 IV q8h\n+\nGentamicin 5 mg/kg\ndaily IV for 7-10 days",
          ""
        ],
        [
          "Chorio-amnionitsi\n(Sepsis)",
          "Inj Piperacillin-tazobactam\n4.5g IV q6h for 7-14 days",
          "Imipenem 500mg IV\nq6h / Meropenem 1-2g\nIV q8h\n+/-\nAmikacin 15 mg/kg IV\nOD\nfor 7-10 days",
          "If the patient is in\nseptci shock, consider\nadding Vancomycin or\nTeicoplanin to cover\nMRSA."
        ]
      ],
      "bbox": [
        72.20400333404541,
        315.0019897460937,
        551.2000122070312,
        571.7080322265625
      ],
      "table_number": 0,
      "extraction_method": "standard"
    }
  ],
  "italic_text": [
    "i.e.",
    "e.g",
    "C. sordelli",
    "C. perfringens",
    "Urethral discharge syndrome",
    "National Technical Guidelines on Sexually Transmitted Infections and Reproductive Tract",
    "Infections (2024). Pg 34-38. National AIDS Control Organization, Ministry of Health and Family Welfare,",
    "Government of India.2024.",
    "Chorio-amnionitis"
  ],
  "dimensions": {
    "width": 595.3200073242188,
    "height": 841.9199829101562
  }
}